Progress Toward Cures: Thoughts at Year’s End from Breakthrough T1D’s CEO
Breakthrough T1D CEO Aaron Kowalski, Ph.D., weighs in on the exciting news surrounding stem cell-derived beta cell replacement therapies, now in human clinical trials.
NFL Superstars Wear Their Hearts on Their Cleats
NFL Superstars across the league are donning custom designed cleats in support of Breakthrough T1D.
Find Your Something
A resident physician and T1D dad—who also lives with an autoimmune disease—shares his call to action to support Breakthrough T1D and research to cure T1D and improve lives.
Managing Diabetes During the Holidays
What’s your strategy for managing your diabetes during the holidays? The Breakthrough T1D-Beyond Type 1 Alliance offers tips to ensure you can enjoy without worry.
NFL Miami Dolphins and Breakthrough T1D Ambassador Blake Ferguson Snaps Hard for Cures!
NFL long snapper for the Miami Dolphins Blake Ferguson is a T1D Champion! Learn how he's helping Breakthrough T1D win in the fight against T1D.
First-in-Human Gene-Edited Stem Cell Trial? Check.
ViaCyte, a beta cell replacement company long supported by Breakthrough T1D, and CRISPR Therapeutics have a new first: Gene-editing for type 1 diabetes.
The Bonds of Family and the Power of Fiction
Author Eve Yohalem interviews her sister about life with type 1 diabetes and the power of fiction to make diabetes a normal part of humanity.
First-in-Human T1D Vaccine Trial Reports Positive Results
A first-in-human study of the coxsackie B vaccine—made by Breakthrough T1D-funded researchers Drs. Hyoty and Knip—reports positive results.
Artificial pancreas systems: Sleeping without fear
Research shows Artificial Pancreas Systems can help improve diabetes-related outcomes and lighten the burden of T1D. Even during sleep.
Smart Insulin Pen/Smart Cap Bridge Technology Gap for MDI
People living with T1D who prefer multiple daily injections (MDI) of insulin now have two high-tech management options: An insulin smart pen or an insulin smart pen cap.
